SCHEMBL1571314

SCHEMBL1571314

CC(COc1cc(Nc2ncc3cc(C#C[Si](C)(C)C)ccc3n2)cc(-c2cnn(CI)c2)c1)NC(=O)OC(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 3/20 0.30
▸ MAP4K1 Q92918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572814 0.91 GSK3B (0.38) MAP4K1
SCHEMBL1571672 0.91 GSK3B (0.38) MAP4K1
SCHEMBL1572812 0.91 GSK3B (0.38) MAP4K1
SCHEMBL1571982 0.82 DDR2 (0.36) BRAFMAP4K1
SCHEMBL1573257 0.80 GSK3B (0.35) BRAF
SCHEMBL1573258 0.80 GSK3B (0.35) BRAF
SCHEMBL1571351 0.79 GSK3B (0.39) BRAFMAP4K1
SCHEMBL13362831 0.79 GSK3B (0.41) BRAFMAP4K1
SCHEMBL1571237 0.79 GSK3B (0.41) BRAFMAP4K1
SCHEMBL1571239 0.79 GSK3B (0.41) BRAFMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307385-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES Novartis AG (CH) 2011-04-13 — — EP disclosed
WO-2009153313-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2009-12-23 — — WO disclosed
Send feedback